U.S. Department of Health and Human Services, National Institutes of Health
Cancer Control
Key facts
Open now
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) · Due Oct 19, 2026 · 12 days left
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) · Due Oct 19, 2026 · 12 days left
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) · Due Nov 5, 2026 · 29 days left
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) · Due Nov 16, 2026 · 40 days left
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) · Due Nov 18, 2026 · 42 days left
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) · Due Nov 18, 2026 · 42 days left
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) · Due Jan 7, 2027 · 92 days left
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) · Due Jan 7, 2027 · 92 days left
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) · Due Jan 7, 2027 · 92 days left
- Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) · Due Jan 25, 2027 · 110 days left
- The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional) · Due Feb 18, 2027 · 134 days left
- Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) · Due Mar 6, 2027 · 150 days left
- Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) · Due May 7, 2027 · 212 days left
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) · Due Jul 12, 2027 · 278 days left
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) · Due Jul 17, 2027 · 283 days left
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) · Due Sep 7, 2027 · 335 days left
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) · Due Sep 7, 2027 · 335 days left
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) · Due Oct 19, 2027 · 377 days left
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) · Due Oct 25, 2027 · 383 days left
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) · Due Oct 25, 2027 · 383 days left
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) · Due Oct 25, 2027 · 383 days left
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) · Due Jan 7, 2028 · 457 days left
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) · Due Jan 7, 2028 · 457 days left
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) · Due Jan 7, 2028 · 457 days left
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) · Due Jan 7, 2028 · 457 days left
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) · Due Jan 7, 2028 · 457 days left
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) · Due Jan 7, 2028 · 457 days left
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) · Due May 4, 2028 · 575 days left
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) · Due Sep 7, 2028 · 701 days left
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) · Due Sep 7, 2028 · 701 days left
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) · Due Nov 30, 2028 · 785 days left
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) · Due Apr 17, 2029 · 923 days left
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) · Due Jun 20, 2029 · 987 days left
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) · Due Jul 5, 2029 · 1002 days left
Opening soon
Announced, but you can't apply yet. Get ready now.
- Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) · The funder's estimated date (Nov 5, 2025) has passed. Check the official notice Estimate, not confirmed by the funder
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) · The funder's estimated date (Jun 30, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- NIH Research Program Projects (Parent P01 Clinical Trial Optional) · The funder's estimated date (Sep 25, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) · The funder's estimated date (Oct 5, 2026) has passed. Check the official notice Estimate, not confirmed by the funder
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) · Due about Nov 2, 2026 Estimate, not confirmed by the funder
- NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) · Due about Nov 20, 2026 Estimate, not confirmed by the funder
- Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) · Opens Apr 1, 2027 · due about Jun 11, 2027 Estimate, not confirmed by the funder
- Investigator-Focused Award (Parent R35) · Opens May 27, 2027 · due about Oct 4, 2027 Estimate, not confirmed by the funder
What it pays for
To reduce cancer risk, incidence, morbidity, and mortality and enhance quality of life in cancer survivors through an orderly sequence from research on interventions and their impact in defined populations to the broad, systematic application of the research results through dissemination and diffusion strategies. Primary emphasis is on the inclusion of cancer prevention and control intervention(s) in any proposed study. Cancer Prevention and Cancer Control research studies are classified into one of five phases: (1) Hypothesis development; (2) methods development and testing; (3) controlled intervention trials to establish cause-and-effect relationships; (4) research in defined populations; and (5) demonstration and implementation studies. Primary interests are in research on cancer control interventions in Phases 2 through 5, and on cancer prevention research in all phases. Cancer Prevention and Control programs include those in the following areas: (1) cancer epidemiology; (2) cancer communications; (3) nutrition, diet, and physical activity; (4) screening and early detection in health care delivery; (5) biobehavioral mechanisms; (6) tobacco control; (7) health disparities research; (8) supportive care and survivorship; (9) health services and outcomes research; and (10) surveillance research. Cancer Control uses Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs to engage domestic small business concerns in federal research and development that has potential for commercialization. The goals of the SBIR & STTR Programs are...
Who can apply
The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that submits an application and receives a grant or cooperative agreement for support of research by a named principal investigator. SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed, and have no more than 500 employees). Primary employment (more than one- half time) of the principal investigator must be with the small business at the time of award and for the duration of the project period. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit, technical merit, and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concern (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. The...
How applications are judged
The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives.
Match
None required (federal program listing).
Who in Tennessee has won this program
3 awards to Tennessee groups since 2005 · 0 in Henry County. Largest shown:
| Past winner | Where | Amount | Fiscal year |
|---|---|---|---|
| Baptist Memorial Hospital-Tipton | Covington, Tipton County | $11.9M | 2014 |
| St Jude Children's Research Hospital Inc | Memphis, Shelby County | $6.8M | 2005 |
| Baptist Memorial Health Care Corporation | Memphis, Shelby County | $1.5M spent that year | 2025 |
Source: USAspending.gov, Federal Audit Clearinghouse.
Tennessee groups that got this money through a state agency or another organization
This federal money also reaches local groups as pass-through grants. 9 pass-through grants on file · 0 in Henry County. Largest shown:
| Past winner | Where | Through | Amount | Fiscal year |
|---|---|---|---|---|
| St. Jude Children's Research Hospital, Inc. | Memphis, Shelby County | Children's Hospital of Philadelphia | $47K spent that year | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Wake Forest University Health Sciences | $38K spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Public Health Institute | $28K spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Alliance for Clinical Trials in Oncology Foundation | $18K spent that year | 2025 |
| St. Jude Children's Research Hospital, Inc. | Memphis, Shelby County | Cog - Ncorp | $13K spent that year | 2025 |
| Baptist Memorial Health Care Corporation | Memphis, Shelby County | Oregon Health and Science University | $6,667 spent that year | 2025 |
| St. Jude Children's Research Hospital, Inc. | Memphis, Shelby County | Cog - Ncorp | $5,856 spent that year | 2024 |
| State of Tennessee | Nashville | Nrg Oncology Foundation, Inc | $1,022 spent that year | 2024 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Ecog-Acrin - Eastern Cooperative Oncology Group | — spent that year | 2023 |
Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).